RECORDATI RARE DISEASES

Recordati Rare Diseases Inc. (RRD) is a biopharmaceutical company committed to providing therapies to the underserved and often overlooked rare disease communities of the United States. Recordati Rare Diseases is part of the rare diseases business within the Recordati Group, a public international pharmaceutical company committed to the research and development of new therapeutics with a focus on treatments for rare diseases... Recordati Rare Diseases UK is a pharmaceutical company that provides treatment for patients with rare diseases. Created in 1990 (as Orphan Europe), Recordati Rare Diseases is active in the field of rare diseases.

Also known as: Recordati, Recordati AB, Recordati BVBA, Recordati Group, Recordati Rare Diseases Australia PTY Ltd, Recordati Rare Diseases Canada Inc., Recordati Rare Diseases Colombia S.A.S., Recordati Rare Diseases Foundation, Recordati Rare Diseases Germany GmbH, Recordati Rare Diseases Inc., Recordati Rare Diseases KK, Recordati Rare Diseases Ltd., Recordati Rare Diseases Spain S.L.U., Recordati Rare Diseases Srl., Recordati Rare Diseases UK, Recordati Rare Diseases, SARL, RECORDATI RARE DISEASES, Société à Responsabilité Limitée, Recordati S.p.A.

Primary location: Bridgewater United States